Transdermal delivery systems (TDS) provide therapy for periods between one and seven days. The increase in the interval between applications favours patient compliance and, in certain cases, optimizes caregivers work.
Another advantage of transdermal administration of drugs is the possibility of reaching sustained and controllable plasma levels of the drug, avoiding the characteristic peaks and valleys of the oral or injectable routes of administration, thus decreasing the risk of potential side effects or lack of activity.
We have also developed an “enhancer” technology applied on semi-solid dosage forms. The drug permeation using this technology allows us to reach therapeutic levels of drugs in the bloodstream.
Transdermal technology offers business opportunities since it represents a market segment with few players and major sales. Transdermal Delivery Systems (TDSs) offer an attractive alternative to oral drug delivery because they are a non-invasive route for drug administration ensuring predictable drug plasma levels and patient compliance improvement.
TDS for the delivery
of liquid drugs
Bilayer Drug-in-Adhesive Design
Our developed products have shown bioequivalence with the reference products *
*AUCs and Cmax T/R ratios close to 100%
We offer expertise and experience, together with flexibility and the ability to adapt to your needs.
“En caso de recopilar Datos Personales por formulario web, se deberán redactar las Políticas de Privacidad de acuerdo a lo exigido por la Ley 25.326 de “Tratamiento de Datos Personales – Habeas Data” y la Ley 24766 de “Confidencialidad de los datos” en Argentina.”